Merck opens production facility exclusively for meglumine in Spain
The only facility in Europe solely dedicated to meglumine production
19-Jan-2017 -
Merck announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.The facility, validated by the FDA, is the only location in Europe that manufactures ...
amino sugars
excipients
Life Sciences
+3